Legal & General Group’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $957K | Buy |
54,825
+19,484
| +55% | +$340K | ﹤0.01% | 2256 |
|
|
2025
Q1 | $445K | Sell |
35,341
-70
| -0.2% | -$881 | ﹤0.01% | 2434 |
|
|
2024
Q4 | $374K | Buy |
35,411
+1,489
| +4% | +$15.7K | ﹤0.01% | 2560 |
|
|
2024
Q3 | $492K | Buy |
33,922
+2,715
| +9% | +$39.4K | ﹤0.01% | 2463 |
|
|
2024
Q2 | $266K | Buy |
31,207
+3,550
| +13% | +$30.2K | ﹤0.01% | 2629 |
|
|
2024
Q1 | $283K | Sell |
27,657
-500
| -2% | -$5.11K | ﹤0.01% | 2621 |
|
|
2023
Q4 | $154K | Hold |
28,157
| – | – | ﹤0.01% | 2735 |
|
|
2023
Q3 | $106K | Buy |
28,157
+3,178
| +13% | +$12K | ﹤0.01% | 2822 |
|
|
2023
Q2 | $167K | Sell |
24,979
-39,564
| -61% | -$265K | ﹤0.01% | 2770 |
|
|
2023
Q1 | $420K | Buy |
+64,543
| New | +$420K | ﹤0.01% | 2366 |
|
|
2022
Q2 | – | Sell |
-1,642
| Closed | -$6K | – | 3647 |
|
|
2022
Q1 | $6K | Hold |
1,642
| – | – | ﹤0.01% | 3493 |
|
|
2021
Q4 | $11K | Sell |
1,642
-2,069
| -56% | -$13.9K | ﹤0.01% | 3444 |
|
|
2021
Q3 | $37K | Buy |
3,711
+2,668
| +256% | +$26.6K | ﹤0.01% | 3063 |
|
|
2021
Q2 | $32K | Sell |
1,043
-265
| -20% | -$8.13K | ﹤0.01% | 3116 |
|
|
2021
Q1 | $57K | Buy |
1,308
+1,295
| +9,962% | +$56.4K | ﹤0.01% | 2784 |
|
|
2020
Q4 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 3478 |
|